And it so happened that just months before Emily was admitted to the hospital, a new therapy had been approved by the FDA to treat elevated levels of interleukin-6.
Y resulta que justo unos meses antes de que Emily ingresara al hospital, la FDA había aprobado una nueva terapia para tratar los niveles altos de interleucina-6.